Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Trial

Young Ju Jeong, Min Ah Kwak, Jung Chul Seo, Seong Hoon Park, Jin Gu Bong, Im Hee Shin, Sung Hwan Park, Young Ju Jeong, Min Ah Kwak, Jung Chul Seo, Seong Hoon Park, Jin Gu Bong, Im Hee Shin, Sung Hwan Park

Abstract

Objectives: Some chemotherapy drugs can damage the nerves and cause peripheral neuropathy which is accompanied by severe neuropathic pain or gait impairment. The purpose of this study was to assess the feasibility and the safety of acupuncture for the treatment of peripheral neuropathy following chemotherapy in Korean breast cancer patients.

Design: This study was a prospective single-arm observational study using before and after measurements in breast cancer patients presenting with taxane-induced peripheral neuropathy.

Settings/location: This study was performed at East-West Medical Center at Daegu Catholic University Hospital, Daegu, South Korea.

Interventions: Acupuncture was administered 3 times a week for 4 consecutive weeks, for 25 ± 5 minutes at each session.

Outcome measures: The primary outcome measure was severity of CIPN using the Neuropathic Pain Symptom Inventory (NPSI) assessed by a self-administered questionnaire and Nerve Conduction Study (NCS) of extremities. The secondary outcome measure was quality of life (QoL) assessed by a self-administered questionnaire using the 36-Item Short From Health Survey (SF-36).

Results: Acupuncture significantly reduced the severity of CIPN assessed by NPSI score. Four weeks after the last treatment, the symptoms were not aggravated. According to NCS, 42.9% of participants showed improvement of sensory neuropathy. At the end of the treatment, SF-36 scores were significantly increased for variables including physical functioning, role limitations due to physical health problems, social functioning, and general health perceptions compared to those of baseline measurement.

Conclusions: Acupuncture improved symptoms of CIPN and QoL in Korean women suffering from peripheral neuropathy after chemotherapy using taxane for breast cancer. The effects of acupuncture lasted for at least 1 month after the treatment.

Figures

Figure 1
Figure 1
A schema of the study visits and measurements.
Figure 2
Figure 2
Anatomical position of acupuncture points prescriptions.
Figure 3
Figure 3
Changes in mean scores of the Neuropathic Pain Symptom Inventory (NPSI) over time: (a) mean NPSI score for burning pain, (b) pressing pain, (c) paroxysmal pain, (d) evoked pain, (e) dysesthesia/paresthesia, and (f) total NPSI score.

References

    1. GLOBOCAN 2012. Estimated cancer incidence, mortality and prevalence worldwide in 2012. Lyon: International Agency for Research on Cancer. , accessed March 15th, 2018.
    1. Jung K.-W., Won Y.-J., Oh C.-M., et al. Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2014. Cancer Research and Treatment. 2017;49(2):292–305. doi: 10.4143/crt.2017.118.
    1. American Cancer Society. Breast Cancer Facts & Figures 2017-2018. Atlanta, GA, USA: American Cancer Society, Inc; 2017.
    1. Gradishar W. J. Taxanes for the treatment of metastatic breast cancer. Breast Cancer: Basic and Clinical Research. 2012;6(1):159–171. doi: 10.4137/BCBCR.S8205.
    1. Ocean A. J., Vahdat L. T. Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies. Supportive Care in Cancer. 2004;12(9):619–625. doi: 10.1007/s00520-004-0657-7.
    1. Speck R. M., Sammel M. D., Farrar J. T., et al. Impact of chemotherapy-induced peripheral neuropathy on treatment delivery in nonmetastatic breast cancer. Journal of Oncology Practice. 2013;9(5):e234–e240. doi: 10.1200/JOP.2012.000863.
    1. Hershman D. L., Lacchetti C., Dworkin R. H., et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology. 2014;32(18):1941–1967. doi: 10.1200/jco.2013.54.0914.
    1. Brami C., Bao T., Deng G. Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: a systematic review. Critical Review in Oncology/Hematology. 2016;98:325–334. doi: 10.1016/j.critrevonc.2015.11.014.
    1. Pachman D. R., Watson J. C., Loprinzi C. L. Therapeutic strategies for cancer treatment related peripheral neuropathies. Current Treatment Options in Oncology. 2014;15(4):567–580. doi: 10.1007/s11864-014-0303-7.
    1. Dimitrova A., Murchison C., Oken B. Acupuncture for the treatment of peripheral neuropathy: a systematic review and meta-analysis. The Journal of Alternative and Complementary Medicine. 2017;23(3):164–179. doi: 10.1089/acm.2016.0155.
    1. Shiqiang Z., Tingting W., Haisheng Z., et al. Effect of electroacupuncture on chemotherapy-induced peripheral neuropathy in patients with malignant tumor: a single-blinded, randomized controlled trial. Journal of Traditional Chinese Medicine. 2017;37(2):179–184. doi: 10.1016/S0254-6272(17)30042-0.
    1. Donald G. K., Tobin I., Stringer J. Evaluation of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Acupuncture in Medicine. 2011;29(3):230–233. doi: 10.1136/acupmed.2011.010025.
    1. Schroeder S., Meyer-Hamme G., Epplée S. Acupuncture for chemotherapy-induced peripheral neuropathy (CIPN): a pilot study using neurography. Acupuncture in Medicine. 2012;30(1):4–7. doi: 10.1136/acupmed-2011-010034.
    1. Ben-Arye E., Shavit E., Wiental H., Schiff E., Agour O., Samuels N. Overcoming communication challenges in integrative supportive cancer care: The integrative physician, the psycho-oncologist, and the patient. Complementary Therapies in Medicine. 2016;29:9–15. doi: 10.1016/j.ctim.2016.09.001.
    1. Lu Z., Moody J., Marx B. L., Hammerstrom T. Treatment of Chemotherapy-Induced Peripheral Neuropathy in Integrative Oncology: A Survey of Acupuncture and Oriental Medicine Practitioners. The Journal of Alternative and Complementary Medicine. 2017;23(12):964–970. doi: 10.1089/acm.2017.0052.
    1. Miller A. B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 1981;47(1):207–214. doi: 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>;2-6.
    1. Deadman P., Baker K., Al-Khafaji M. A Manual of Acupuncture. 2nd. East Sussex, UK: 2007. (Journal of Chinese Medicine Publications).
    1. Wong R., Sagar S. Acupuncture treatment for chemotherapy-induced peripheral neuropathy - A case series. Acupuncture in Medicine. 2006;24(2):87–91. doi: 10.1136/aim.24.2.87.
    1. Kaptchuk T. J. Acupuncture: theory, efficacy, and practice. Annals of Internal Medicine. 2002;136(5):374–383. doi: 10.7326/0003-4819-136-5-200203050-00010.
    1. Bouhassira D., Attal N., Fermanian J., et al. Development and validation of the neuropathic pain symptom inventory. Pain. 2004;108(3):248–257. doi: 10.1016/j.pain.2003.12.024.
    1. Oh S. J. Clinical Electromyography Nerve Conduction Studies. 3rd. Philadelphia, PA, USA: Lippincott Williams & Wilkins; 2003.
    1. Ware J. E., Sherbourne C. D. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Medical Care. 1992;30(6):473–483. doi: 10.1097/00005650-199206000-00002.
    1. Ware Jr J. E., Snow K. K., Kosinski M., Gandek B. SF36 Health Survey: Manual and Interpretation Guide. Boston, MA, USA: New England Medical Center, The Health Institutue; 1993.
    1. Man P. L. Acupuncture analgesia for the treatment of trigeminal neuralgias: a series of forty-one cases. Journal of the National Medical Association. 1975;67(2):115–117.
    1. Franconi G., Manni L., Schröder S., Marchetti P., Robinson N. A systematic review of experimental and clinical acupuncture in chemotherapy-induced peripheral neuropathy. Evidence-Based Complementary and Alternative Medicine. 2013;2013:7. doi: 10.1155/2013/516916.516916
    1. Ben-Horin I., Kahan P., Ryvo L., Inbar M., Lev-Ari S., Geva R. Acupuncture and reflexology for chemotherapy-induced peripheral neuropathy in breast cancer. Integrative Cancer Therapies. 2017;16(3):258–262. doi: 10.1177/1534735417690254.
    1. Xiong Z., Wang T., Gan L., Ran J., Min J., Lü G. Clinical efficacy of acupoint injection for chemotherapy-induced peripheral neuropathy of patients with breast cancer. World Journal of Acupuncture - Moxibustion. 2016;26(2):20–24. doi: 10.1016/S1003-5257(17)30005-3.
    1. Addington J., Freimer M. Chemotherapy-induced peripheral neuropathy: an update on the current understanding. F1000Research. 2016;5:p. 1466. doi: 10.12688/f1000research.8053.1.
    1. Ventzel L., Jensen A. B., Jensen A. R., Jensen T. S., Finnerup N. B. Chemotherapy-induced pain and neuropathy: A prospective study in patients treated with adjuvant oxaliplatin or docetaxel. Pain. 2016;157(3):560–568. doi: 10.1097/j.pain.0000000000000404.
    1. Bao T., Zhang R., Badros A., Lao L. Acupuncture treatment for bortezomib-induced peripheral neuropathy: a case report. Pain Research & Management. 2011;2011:4. doi: 10.1155/2011/920807.920807
    1. Kim J.-H., Kim E.-J., Seo B.-K., et al. Electroacupuncture for chemotherapy-induced peripheral neuropathy: Study protocol for a pilot multicentre randomized, patient-assessor-blinded, controlled trial. Trials. 2013;14(1):1–7. doi: 10.1186/1745-6215-14-1.
    1. Leone C., Biasiotta A., La Cesa S., Di Stefano G., Cruccu G., Truini A. Pathophysiological mechanisms of neuropathic pain. Future Neurology. 2011;6(4):497–509. doi: 10.2217/fnl.11.23.
    1. Mols F., Beijers T., Vreugdenhil G., Van De Poll-Franse L. Chemotherapy-induced peripheral neuropathy and its association with quality of life: A systematic review. Supportive Care in Cancer. 2014;22(8):2261–2269. doi: 10.1007/s00520-014-2255-7.
    1. Zhang Y., Qu B., Lun S., Guo Y., Liu J. The 36-item short form health survey: reliability and validity in chinese medical students. International Journal of Medical Sciences. 2012;9(7):521–526. doi: 10.7150/ijms.4503.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere